- E-mail : info@wellonapharma.com
- Call : +91-261-2571244
- Mob: +91-7490041245
Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reducing the risk of macrovascular complications.
Apperance: white crystalline powder
Specification:
|
Items |
Standards |
|
Appearance |
White to almost white powder |
|
Solubility |
---------- |
|
Melting point |
163~168°C |
|
Specific Rotation |
+45°~ +48° |
|
Identification |
1) The IR absorption spectrum of the sample is concordant with that of Voglibose reference standard 2) HPLC |
|
Acidity |
9.4 ~10.4 |
|
Related Substances(HPLC) |
Total impurity≤0.2% |
|
Water |
≤0.5% |
|
Residue on ignition |
≤0.2% |
|
Heavy metals |
≤10ppm |
|
Assay(on dried basis) |
99.5%-101.0% |
Packaging details:
|
Packaging details: |
25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum. |
|
Storage: |
Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat |
|
Shelf Life: |
5 years if sealed and store away from direct sun light. |
